Industry Insights

Home » Industry Insights
2209, 2017

Healthcare-Associated Gram-Negative Market to be Worth $3.6 Billion by 2026

By |September 22nd, 2017|Categories: Market insights, News, Pharmaceutical|Tags: |0 Comments

The global marketplace for healthcare-associated infections (HAIs) caused by Gram-negative bacteria across the seven major pharmaceutical markets (7MM) is projected to exceed $3.6 billion in sales by 2026, at a compound annual growth rate (CAGR) [...]

2209, 2017

ABL Acquisition Extends Ardena’s Early Phase Offering

By |September 22nd, 2017|Categories: Business and Finance, News, Pharmaceutical|Tags: , |0 Comments

Early phase contract development and manufacturing organisation (CDMO), Ardena, has acquired bioanalytical contract laboratory, Analytical Biochemical Laboratory (ABL). The acquisition of Netherlands-based ABL follows the merging of Pharmavize and Crystallics to form Ardena and broadens [...]

2109, 2017

Boris Johnson Stresses “Importance of the Life Sciences Sector to the UK Economy” at TraceLink’s New European HQ launch

By |September 21st, 2017|Categories: Business and Finance, News, Pharmaceutical|Tags: |0 Comments

From left to right: Carter Holland CMO, Jean-Marie Aulnette, VP of EMEA sales, Boris Johnson and Cllr Ray Pudifoot Foreign Secretary Boris Johnson has officially opened TraceLink’s new European headquarters in Uxbridge, UK. [...]

2109, 2017

Synpromics Announces Gene Therapy Research Partnership with Solid Biosciences

By |September 21st, 2017|Categories: Drug Discovery & Development, News, Pharmaceutical|Tags: , |0 Comments

Synpromics Ltd, the leader in gene control, has announced a new research partnership with Solid Biosciences. Under the terms of the agreement, Synpromics will provide Solid Biosciences access to a set of key muscle-selective promoter [...]

2009, 2017

Recipharm Signs Long-Term Manufacturing Agreement and Acquires Facility in Spain

By |September 20th, 2017|Categories: Business and Finance, News, Pharmaceutical|Tags: , |0 Comments

Recipharm AB announces that it has entered into a collaboration with Roche and signed a long-term manufacturing agreement whereby Recipharm will manufacture a range of solid dose products. Recipharm will also acquire a manufacturing facility [...]

2009, 2017

Catalent to Acquire Cook Pharmica for $950 Million

By |September 20th, 2017|Categories: Business and Finance, News, Pharmaceutical|Tags: , |0 Comments

Catalent, Inc. the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has reached an agreement to acquire Bloomington, Indiana-based Cook Pharmica LLC, an integrated provider of [...]